Informing Optimal Pricing Strategies With A Comprehensive Modeling Approach

Strategic pricing has become especially pivotal following the passing of the Inflation Reduction Act (IRA) which gives manufacturers less flexibility to adjust their pricing strategies. Establishing the right price at commercial launch is critical now more than ever for commercial success.

Pricing not only directly impacts market access and patient adherence, it also affects the development of optimal payer contracts and the ability to provide discounts that maximize access while still protecting manufacturers’ gross-to-net. Manufacturers must consider the three key stakeholders – payers, physicians and patients – and collect appropriate data to accurately determine their reactions to various price points. Explore the pricing strategy challenges facing manufacturers and how combining tailored primary research insights and analytic solutions is key for optimizing pricing, contracting, and access strategies.